Compounding Pharmacy · Est. 2017 · Springville, UT · 503A
Red Rock Pharmacy Review
Red Rock Pharmacy (CD Pharmacy LLC) is a Utah-based 503A state-licensed compounding pharmacy with locations in Springville and St. George. Its Springville site serves every state except California, Nevada, and Arkansas, and the St. George site serves California and Nevada, for 49 states in all. Produces sterile injectables including compounded semaglutide and tirzepatide. FDA issued a Form 483 to the Springville facility in July 2026.
Red Rock fills compounded GLP-1 orders for programs including Fridays and LeanMeds. Its record shows a state license rather than PCAB accreditation; Utah residents can compare other programs on our Utah GLP-1 telehealth page.
1 FDA, state or legal action on record. Most recent: FDA Form 483 (Jul 31, 2026) — see the full record below.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Regulatory Actions
Telehealth Providers Sourcing From This Pharmacy
These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Red Rock Pharmacy. Sourcing arrangements can change over time.
Found
Best for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Mochi Health
Best for: insurance help for brand-name GLP-1s, or self-pay compounded GLP-1 priced by dose
Editorial score · methodology
Fridays
Best for: compounded or brand GLP-1 bundled with nutrition and mental health coaching, insurance support and an app
Editorial score · methodology
Hims
Best for: people who want brand-name GLP-1 pills or pens through a big-name app with 24/7 messaging
Editorial score · methodology
Editorial score · methodology
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (49)
External Reviews
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology (as of November 2026)
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.